Deputy Center Director | Regulatory Programs of the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research
Sarah Ibrahim, BPharm, PhD, is a regulatory strategist with more than 20 years of experience spanning the U.S. Food and Drug Administration, pharmaceutical development, and global regulatory affairs. A former FDA scientific reviewer in the Office of Pharmaceutical Quality, she has advised on hundreds of IND, NDA, BLA, and 505(b)(2) submissions and has extensive experience developing regulatory strategies that support efficient product development and approval.
Dr. Ibrahim has worked closely with FDA and other global health authorities, guiding organizations through complex regulatory challenges and evolving approval pathways. She holds a Ph.D. in Biopharmaceutics/Pharmaceutics from the University of Cincinnati and a B.S. in Pharmacy and Pharmaceutical Sciences from Cairo University.
